Evidence map›Paper›PMID 26235283›Full record

ArticleScientific reports2015

Ion channel gene expression predicts survival in glioma patients.

Rong Wang, Christopher I Gurguis, Wanjun Gu, Eun A Ko, Inja Lim, Hyoweon Bang, Tong Zhou, Jae-Hong Ko

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 41 papers.

0numbers the graph read from it
0cells of the map it votes in
41citing papers in PubMed
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

41 citing papers in PubMed, 53 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Review
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Age-dependent expression of ion channel genes in rat.The Korean journal of physiology & pharmacology : official journal of the Korean Physiological Society and the Korean Society of Pharmacology · 2023
    Article
  13. Article
  14. Transient Receptor Potential (TRP) Channels in Tumor Vascularization.International journal of molecular sciences · 2022
    Review
  15. The Journal of international medical research · 2022
    Article
  16. Review
  17. Ion Channels in Cancer: Orchestrators of Electrical Signaling and Cellular Crosstalk.Reviews of physiology, biochemistry and pharmacology · 2022
    Review
  18. Article
  19. Article
  20. Alterations in the CaExploration of targeted anti-tumor therapy · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 5 institutions in 3 countries.

Rong WangDepartment of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu 215006, China.
Christopher I GurguisDepartment of Medicine, University of Arizona, Tucson, AZ 85721, USA.
Wanjun GuResearch Center for Learning Sciences, Southeast University, Nanjing, Jiangsu 210096, China.
Eun A KoDepartment of Pharmacology, University of Nevada School of Medicine, Reno, NV 89557, USA.
Inja LimDepartment of Physiology, College of Medicine, Chung-Ang University, Seoul 156-756, South Korea.
Hyoweon BangDepartment of Physiology, College of Medicine, Chung-Ang University, Seoul 156-756, South Korea.
Tong ZhouDepartment of Medicine, University of Arizona, Tucson, AZ 85721, USA.
Jae-Hong KoDepartment of Physiology, College of Medicine, Chung-Ang University, Seoul 156-756, South Korea.
Chung-Ang University · KRUniversity of Arizona · USFirst Affiliated Hospital of Soochow University · CNSoutheast University · CNUniversity of Nevada, Reno · US

Funding

Selectively targeting delta opioid receptor subtypes to control drinking behaviorR01AA020401 · NIAAA · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI WHISTLER, JENNIFER L · 2011 to 2015
$1.8M
NIAAA NIH HHS R01 AA020401
6 · The paper itself

Abstract

Ion channels are important regulators in cell proliferation, migration, and apoptosis. The malfunction and/or aberrant expression of ion channels may disrupt these important biological processes and influence cancer progression. In this study, we investigate the expression pattern of ion channel genes in glioma. We designate 18 ion channel genes that are differentially expressed in high-grade glioma as a prognostic molecular signature. This ion channel gene expression based signature predicts glioma outcome in three independent validation cohorts. Interestingly, 16 of these 18 genes were down-regulated in high-grade glioma. This signature is independent of traditional clinical, molecular, and histological factors. Resampling tests indicate that the prognostic power of the signature outperforms random gene sets selected from human genome in all the validation cohorts. More importantly, this signature performs better than the random gene signatures selected from glioma-associated genes in two out of three validation datasets. This study implicates ion channels in brain cancer, thus expanding on knowledge of their roles in other cancers. Individualized profiling of ion channel gene expression serves as a superior and independent prognostic tool for glioma patients.

Indexed as

Biomarkers, TumorDatabases, GeneticGene Expression Regulation, NeoplasticGliomaHumansIon ChannelsKaplan-Meier EstimateLoss of HeterozygosityNeoplasm GradingPrognosisProportional Hazards ModelsBiomarkers, TumorIon Channels

Identifiers

PMID26235283
PMCPMC4522676
OpenAlexW1075217855

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.